Search the Newsreel

Neumora Therapeutics (NASDAQ:NMRA) Insider Daljit Singh Aurora Sells 31,000 Shares

Neumora Therapeutics insider Daljit Singh Aurora sold 31,000 shares of Neumora Therapeutics stock for $1.65 per share, totaling $51,150. This transaction reduced his position by 38.87% to 48,750 shares. The sale is part of a series of transactions from August 17-19, totaling over 246,000 …

Insider Selling: Neumora Therapeutics (NASDAQ:NMRA) Insider Sells 91,690 Shares

Daljit Singh Aurora, an insider at Neumora Therapeutics (NASDAQ:NMRA), sold 91,690 shares of the company's stock for $137,535, significantly reducing his position. This sale is part of several transactions Aurora made during the week. Despite these insider sales and the stock trading near its …

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com

Daljit Singh Aurora, COO and Development Officer at Neumora Therapeutics, sold 277,773 shares of common stock for approximately $431,674 between August 17 and August 19, 2026, while also acquiring 243,753 shares through stock option exercises. The stock has seen a 52% decline over the …

Prenetics Global (PRE) Stock Price Cools As Losses Cloud Revenue Surge

Insider Selling: Universal Electronics (NASDAQ:UEIC) Major Shareholder Sells 8,300 Shares of Stock

Toro 18 Holdings LLC, a major shareholder in Universal Electronics (NASDAQ:UEIC), sold 8,300 shares of the company's stock for approximately $40,089 on August 19th, reducing its stake by 0.65%. This sale is part of a series of disposals by Toro 18 Holdings in August, …

Universal Electronics: 10% owner Toro 18 sells $343k in stock

Toro 18 Holdings LLC, a 10% owner of Universal Electronics Inc. (NASDAQ:UEIC), sold approximately $343,066 worth of company stock across three transactions in mid-August. Despite this insider selling, InvestingPro analysis suggests the stock is undervalued with potential upside, and the company recently reported strong …

Akari (AKTX) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Reaction: Shares Show Limited Movement in the Available Record - Revenue Surprise History

Insider Selling: PACS Group (NYSE:PACS) CEO Sells $2,951,091.46 in Stock

PACS Group CEO Jason Hulse Murray recently sold 66,797 shares of the company's stock for $2.95 million, following a pre-arranged Rule 10b5-1 plan. This sale is part of a larger series of transactions, bringing his total recent sales to nearly $10.44 million, though he …

Proficient Auto (NASDAQ: PAL) officer plans stock sale from Aug. 19

Proficient Auto Logistics, Inc (PAL) officer Amy F. Rice has filed a Rule 144 notice to sell up to 5,808 shares of common stock, valued at $32,605.00, through Stifel Nicolaus & Company Inc on or after August 19, 2026. These shares originated from 21,555 …

Entrada (TRDA) Earnings Update: Profit Per Share Surpasses Its Benchmark on the Day; Share Move: Shares Move Higher 7.02% - Analyst Earnings Estimate

Halozyme Therapeutics (NASDAQ:HALO) CEO Sells 20,000 Shares of Stock

Halozyme Therapeutics CEO Helen Torley sold 20,000 shares of the company's stock for over $2 million, executed under a pre-arranged Rule 10b5-1 trading plan. This transaction reduced her holdings by 2.54%. The company recently exceeded analyst estimates with strong quarterly earnings and revenue growth, …

Roth MKM Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $8

Roth MKM has reiterated its Buy rating for Gain Therapeutics (GANX.US) and maintained its target price of $8. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

Neumora Therapeutics (NMRA) insider plans new stock sale after $329K in recent trades

Neumora Therapeutics (NMRA) officer Daljit Singh Aurora has filed a Rule 144 notice for a planned sale of 61,918 shares of common stock on August 19, 2026, through a broker-assisted cashless sale after exercising employee stock options. This follows previous sales by Aurora in …

Ned S Holmes, Prosperity Bancshares director, sells $81,024 in stock

Ned S. Holmes, a director at Prosperity Bancshares Inc. (NASDAQ:PB), sold common stock worth $81,024 on August 19, 2026, across various transactions. These sales involved both direct and indirect holdings at prices ranging from $72.85 to $74.535 per share. Following these sales, Holmes retains …

LG ELECTRONICS EXPANDS FIT & MAX SOLUTION ACROSS KEY HOME APPLIANCE CATEGORIES AT IFA 2026

Extending the Fit & Max Concept Beyond Refrigerators to More Home Appliances News Summary LG Electronics' expanded Fit & Max Solution, now spanning refrigerators, washing machines, dryers and dishwashers, will be showcased at IFA 2026. 'Fit Space' enables seamless integration into the home, while …

General Dynamics unveils $35 million in updates to Sterling Heights headquarters

Defense contractor General Dynamics Land Systems celebrated a $35 million renovation of its Sterling Heights main office, which had not been updated since 1987. The event featured Michigan and Macomb County officials who highlighted the significance of the state's defense industry. Governor Gretchen Whitmer …

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh

This article is a statement of changes in beneficial ownership of securities for Officer Aurora Daljit Singh at Neumora Therapeutics. It is identified as a Form 4 filing, which indicates a required disclosure of insider trading activity.

PACS Group (NASDAQ: PACS) CEO sells shares in 3-day preset plan

Murray Jason Hulse, Co-Founder, CEO, and Chairman of PACS Group, Inc. (NASDAQ: PACS), sold a total of 236,116 common stock shares between August 17 and 19, 2026. These sales were conducted on the open market under a Rule 10b5-1 trading plan established on May …

Frequency (FEIM) Financial Update: EPS Misses Its Estimate at the Close; Market Move: The Share Price Sheds 11.17% in the Available Record - Earnings Seasonality

Is Quest Diagnostics (DGX) Still Worth A Look After A 92% Run?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Quest Diagnostics stock has delivered a strong 3 year return, yet the current checks present a more nuanced picture, with the Discounted Cash Flow …

STMicroelectronics (ENXTPA:STMPA) Validates ST64UWB Chip Family For New UWB Standard

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. STMicroelectronics (ENXTPA:STMPA) reported that its ST64UWB chip family has achieved successful validation for IEEE …

Simon Read Sells 2,778 Shares of Dianthus Therapeutics (NASDAQ:DNTH) Stock

Relay Therapeutics (RLAY) Reported Q2 Results, Is The Premium P B Multiple Justified?

Relay Therapeutics (RLAY) reported Q2 2026 results with revenue of US$0.35 million and a net loss of US$83.71 million. Despite recent share price recovery, the company's P/B ratio of 5.1x is higher than its peers and the broader biotech industry, suggesting it is overvalued. …

Structure Therapeutics (GPCR) exec sells 3,939 ADSs under plan

Structure Therapeutics' Chief Scientific Officer, Xichen Lin, reported insider activity on August 18, 2026, which included exercising options for 11,817 Ordinary Shares and converting them into 3,939 American Depositary Shares (ADSs). All 3,939 ADSs were subsequently sold in three tranches at weighted average prices …

Haemonetics stock hits 52-week high at 106.64 USD By Investing.com

Haemonetics Corp (NYSE:HAE) reached a new 52-week high of $106.64, demonstrating strong performance with a 92.73% one-year return. This surge follows better-than-expected fiscal first-quarter results and a new supply agreement with CSL Plasma Inc. Analysts have also revised earnings upwards, indicating continued positive momentum …

Lexeo Therapeutics (NASDAQ:LXEO) CEO Richard Nolan Townsend Sells 3,345 Shares

Lexeo Therapeutics CEO Richard Nolan Townsend sold 3,345 shares of LXEO stock for $16,557.75 to cover tax-withholding obligations related to vested equity awards. This sale reduced his ownership by 0.89%, leaving him with 374,472 shares. Despite a quarterly loss and some analyst downgrades, LXEO …

Lexeo (NASDAQ: LXEO) CEO sale covers RSU tax bill, keeps 374K shares

Lexeo Therapeutics, Inc. (LXEO) CEO Richard Nolan Townsend sold 3,345 shares of common stock on August 18, 2026, at a weighted average price of $4.9512 per share. This sale was conducted to cover tax obligations arising from the release of restricted stock units (RSUs). …

Halozyme (NASDAQ: HALO) CEO sells tens of thousands of shares

Halozyme (NASDAQ: HALO) President and CEO Helen Torley exercised stock options and sold 60,000 common shares between August 17-19, 2026, under a pre-arranged Rule 10b5-1 trading plan. She exercised options at $18.41 per share and sold the shares in the high $90s to approximately …

Insider Selling: Prosperity Bancshares (NYSE:PB) Director Sells $44,202.00 in Stock

Prosperity Bancshares (NYSE:PB) Director Ned Holmes sold 600 shares of the company's stock for $44,202.00, reducing his position by 1.51%. The company recently reported quarterly EPS of $1.62, beating estimates, and revenue of $369.18 million, which missed expectations. Analysts currently rate Prosperity Bancshares as …

Louis Edward Tamayo Sells 4,117 Shares of Lexeo Therapeutics (NASDAQ:LXEO) Stock

Lexeo Therapeutics CFO Louis Edward Tamayo sold 4,117 shares of LXEO stock for $20,214.47 to cover tax obligations, reducing his stake by 4.24% to 92,907 shares. The company's stock rose to $5.37 during mid-day trading despite missing quarterly EPS estimates, and institutional ownership stands …

Cytokinetics (CYTK) Quarterly Figures: Profit Per Share Clears Its Benchmark for the Current Session; Trading Move: Shares Move 2.16% Up at the Close - EPS Guidance Update

An2 Therapeutics director Robin Readnour sells $212,701 in common stock By Investing.com

Robin Shane Readnour, a director at AN2 Therapeutics (ANTX), sold 35,402 shares of common stock for a total of $212,701 on August 17, 2026. These transactions, executed at an average price of $6.0082 per share, were conducted under Rule 10b5-1 trading plans. Despite the …

Universal Electronics (UEIC) group including Eric Singer sells 66,896 shares

A group including Toro 18 Holdings LLC, Immersion Corporation, William C. Martin, and director Eric Singer, who collectively own over 10% of Universal Electronics (UEIC), sold 66,896 shares of common stock between August 17 and 19, 2026. The sales occurred on the open market …

Total non-current assets of Definium Therapeutics, Inc. – NASDAQ:DFTX

This article focuses on the total non-current assets of Definium Therapeutics, Inc. (NASDAQ: DFTX). It appears to be a financial data page from TradingView, displaying company information and navigational elements for financial analysis. The content indicates market data and reference data providers for the …

Enterprise value to EBITDA forward of Context Therapeutics Inc. – NASDAQ:CNTX

This article displays the Enterprise Value to EBITDA forward for Context Therapeutics Inc. (NASDAQ: CNTX). It provides basic financial information related to the company within the TradingView platform. The content is primarily a data point display from a financial charting service.

Veradermics (MANE) affiliate plans NYSE sale via BofA Securities

Averill Master Fund, Ltd., an affiliate of Veradermics, Inc. (MANE), has filed a Rule 144 notice to sell 690,601 shares of common stock through BofA Securities, Inc. on the NYSE. These shares were obtained from the conversion of Series B Preferred Stock, acquired in …